Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Dec 8;13:21776. doi: 10.1038/s41598-023-48668-3

Socioeconomic status and healthcare utilization disparities among children with epilepsy in the United States: Results from a nationally representative sample

Nallammai Muthiah 1, Scott Rothenberger 2, Taylor J Abel 3,
PMCID: PMC10709331  PMID: 38066038

Abstract

Epilepsy affects 1% of the US population. Healthcare disparities are well-studied among adults with epilepsy but less so among children. We examined whether children with epilepsy (1) have lower income than or (2) utilize the emergency department (ED) differently from children without epilepsy, and (3) if income moderates ED utilization. Data from the 2016–2019 National Survey of Children’s Health were used to identify children with active “epilepsy or seizure disorder”. Children with versus without epilepsy were compared. Income and ED visits were modeled with logistic and Poisson regressions. This analysis included 131,326 children; 835 were diagnosed with epilepsy. Estimated population prevalence of epilepsy was 0.6%. Children from higher-income-households were less likely to have epilepsy (aOR: 0.7). Children with epilepsy were more likely to visit EDs (aOR = 10.2), see healthcare professionals (aOR: 2.7), and receive care from specialists (aOR: 10.3). Income moderated the relationship between having epilepsy and ED visits. 7.7% of children with epilepsy did not receive needed healthcare. Some barriers were acquiring appointments (aOR: 3.9) and transportation (aOR: 4.7). In conclusion, children with epilepsy were more likely than children without epilepsy to live in lower-income-households, visit EDs, see healthcare professionals, and not receive needed healthcare. Barrier-specific policy interventions may improve medical access for children with epilepsy.

Subject terms: Neurology, Neurological disorders, Epilepsy

Introduction

Epilepsy is a common neurological condition characterized by either: (1) two unprovoked seizures occurring at least 24 h apart, (2) one unprovoked seizure with a predisposition for further seizures, or (3) diagnosis of an epilepsy syndrome1. Epilepsy affects approximately 470,000 children in the United States alone2. It is estimated that one-third of these children will have seizures resistant to antiseizure medications (ASMs)3.

Epilepsy is a chronic medical condition, and as such, health-related outcomes for people with epilepsy are influenced socioeconomic factors4. The prevalence of epilepsy is higher among adults with low socioeconomic status (SES)5. At the same time, adults with lower SES are less likely to adhere to their ASM regimen6. Furthermore, Black and Hispanic individuals are 30% and 40% less likely, respectively, to be seen by outpatient neurologists even after accounting for demographic, health status, and insurance differences7. These statistics are alarming considering that the risk of death among people with epilepsy is up to threefold higher than that of the general population8. Moreover, mortality risk is higher for those with poorly controlled epilepsy8,9.

While healthcare disparities are evidenced among adults with epilepsy, the extent and effect of these disparities among children is less studied. It has been suggested that the socioeconomic status of caregivers influences the healthcare, social, and financial outcomes for children with chronic medical conditions, like epilepsy. An important recent systematic review by Huber and Weber (2022) found that children living in lower SES households had lower levels of seizure freedom, antiseizure medication adherence, academic performance, quality of life, and adult income10. This study, however, was a systematic review of studies with varying methodologies and reporting on varied outcomes. To obtain more standardized data (and therefore a more direct analysis of that data), a large sample of children from a single, all-encompassing dataset would be an excellent avenue for correlative analysis. The primary objectives of our study were to examine whether children with epilepsy (1) have lower income than those without epilepsy or (2) utilize healthcare resources (specifically the emergency department) more than those without epilepsy, and (3) if their ED utilization is moderated by income. To address these objectives, we utilized four years of data from the National Survey of Children’s Health (NSCH), a large-scale, nationally representative database of caregiver-provided data which addresses children’s health, family socioeconomic status, and access to medical care.

Methods

Sample

Data for this analysis were derived from the Maternal and Child Health Bureau of the US Health Resources and Services Administration’s National Survey of Children’s Health (NSCH). The NSCH is a household survey which produces national and state-level data on the physical and emotional health of children 0–17 years old in the United States. The dataset is based entirely on caregiver responses to phone questionnaires. A screening questionnaire was first administered to identify households with children as well as the number of children in the household. One child was randomly selected from each eligible household, and that child was the subject of a more detailed topical questionnaire. Responses to the topical questionnaire were weighted to represent the year’s national population. Since 2016, the NSCH has been an annual survey. To date, survey data from 2016 to 2019 are publicly available. Data from the 2016, 2017, 2018, and 2019 datasets were combined for the purposes of this cross-sectional analysis in accordance with the US Census Bureau’s Guide to Multi-Year Analysis11.

After combining datasets, the sample was split into groups based on the selected child’s epilepsy status: children with current, active “epilepsy or seizure disorder” versus children without active “epilepsy or seizure disorder”. Caregivers answered the question: “Has a doctor or other health care provider EVER told you that this child has epilepsy or seizure disorder?”. If the caregiver answered yes, the follow-up question was asked: “Does this child CURRENTLY have the condition?”. Therefore, response options to this question were: that the caregiver “has never been told their child has epilepsy or seizure disorder”, the caregiver “had ever been told the child has epilepsy or seizure disorder, but does not currently have the condition”, and the child “currently has epilepsy or seizure disorder”. Children who had ever been told, but do not currently have, epilepsy remained an ambiguous group. Given that seizures often occur independently from epilepsy, children who “were ever told they had epilepsy or seizure disorder” but did not identify as having active, current epilepsy were coded into the “no epilepsy” group.

Outcome measures

Caregivers answered questions about their household income and their selected child’s healthcare resource utilization. Household income was initially collected as a continuous variable. Subsequently, household income was divided into categories for the publicly available NSCH dataset as percentage income relative to federal poverty level (FPL). Categories were: “0–99% FPL”, “100–199% FPL”, “200–399% FPL”, and “ ≥ 400% FPL”. These categories were used to represent household income.

The selected child’s number of emergency department (ED) visits over the past 12 months was used to reflect healthcare resource utilization. Caregivers answered the following question: “During the past 12 months, how many times did this child visit a hospital emergency room?”. Response options were: “None”, “1 time”, and “2 or more times”.

Statistical analysis

Children with and without epilepsy were compared on caregiver and child sociodemographic measures using second-order Rao-Scott adjusted chi-square tests. Child age was compared using the adjusted Wald test. This analysis used various regression models to model outcomes of interest as a function of epilepsy status, which are described in detail below.

Ordered logistic regressions were used to determine odds ratios of (1) income and (2) ED utilization as a function of the selected child’s epilepsy status. As mentioned, income was divided into FPL categories and number of ED visits was used to represent ED utilization. Ordered logistic regressions were chosen to represent odds ratios because income categories and ED utilization, as mentioned above, were represented as ordered categorical variables in the NSCH dataset. Ordered regressions assume proportional odds (i.e., the relationship between each pair of outcome groups is equal), which allows for creation of a single model to describe relationships between pairs of outcomes and provides a more accurate estimation of probabilities for variables with ordered outcomes.

Multinomial logistic regressions were used to determine relative risk ratios for utilization of specific healthcare services as a function of epilepsy status. For brief context, a risk ratio refers to the cumulative incidence of a given outcome in the “exposed” group (in this case, children with active epilepsy”) divided by the cumulative incidence in the “unexposed” group (here, children without active epilepsy). This allows one to compare the risk of any given outcome between the study’s comparison groups directly. Multinomial logistic regressions were used to estimate risk ratios when survey item of interest contained  > 2 nominal outcome categories (similar to the analysis performed by Miller et al. with this same dataset in 202112). Multinomial logistic regressions were used to model survey items relating to: the place a child typically visits when sick and whether a child received care from a specialist healthcare provider over the last 12 months. When healthcare service variable of interest contained only two categories, a binary logistic regression was used instead to estimate odds ratios as a function of epilepsy status. Binary logistic regressions were used to model survey items relating to: whether the child saw a healthcare professional over the last 12 months, whether a child saw a healthcare professional for a preventative visit over the last 12 months, whether the child received the medical care he/she needed. In the case that needed medical care was not received, binary logistic regressions were also used to estimate odds ratios for the reason contributing to lack of needed medical care (defined by the NSCH as “medical care as well as other kinds of care like dental care, vision care, and mental health services”) was for eligibility issues, unavailability of services, problems getting an appointment, transportation issues, the clinic/doctor’s office not being open, or cost issues as a function of epilepsy status.

Finally, a censored Poisson regression was used to estimate the incidence rate ratios of ED visits as a function of epilepsy status, adjusting for income. As mentioned, ED utilization was also modeled using ordered logistic regressions. However, given that ED visit data as it existed in the dataset was right-censored (ED visits were coded in the dataset as “none”, “1”, or “2 + ”), censored Poisson regressions were felt to provide more accurate estimations of ED utilization. A censored Poisson regression model including an interaction between epilepsy status and income was also developed to determine if there was a moderation effect of income on the relationship between epilepsy status and ED utilization. The interaction term was tested for significance using the adjusted Wald test.

Regressions were adjusted for potential confounders. Specifically, regressions were adjusted for baseline differences between children with and without epilepsy in the baseline demographic analysis as well as differences between these children evidenced in the literature. Ultimately, all regressions were adjusted for child age and child race. For all analyses, p < 0.05 was considered significant. All p-values were two-sided. All statistical analyses were performed using Stata software for Mac, Version 17.0 (StataCorp. 2021. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC.). All analyses followed STROBE Reporting Guidelines.

Standard protocol approvals, registrations, and patient consents

Given that the data used for this analysis are publicly available, no ethical standards committee approval was sought and no individual patient consent was obtained. No invertebrates or vertebrates were utilized for this study. There are no recognizable persons in photographs, videos, or other information in this study, so no authorization was obtained. This is not a clinical trial.

Results

This analysis included data representing 131,326 children, among whom 835 were diagnosed with active epilepsy. The estimated population prevalence of epilepsy was 0.59% given a population size of 73,084,673. Table 1 details the demographic differences between children with versus without epilepsy. Children with epilepsy were significantly older than their peers (9.2 versus 8.6 years), and a larger proportion were black, non-Hispanic (18.2% versus 13.2%). A similar proportion of children with and without epilepsy had healthcare insurance. Caregivers of children in both groups had similar levels of educational achievement. Among children in the “healthy” comparison group, children had other medical conditions elicited by the NSCH which may have impacted their ED utilization in a given year. The prevalence of those conditions among the comparison group was: heart conditions (1.3%), diabetes (0.4%), asthma (8.0%), blood disorders (such as sickle cell disease, thalassemia, or hemophilia) (0.4%), and cystic fibrosis (0.1%).

Table 1.

Child and caregiver characteristics of 0–17-year-old children with versus without active epilepsy from the 2016–2019 NSCH surveys.

No active epilepsy n = 130,491
99.4% [99.3, 99.5]
95% CI of % Active epilepsy n = 835
0.6% [0.5, 0.7]
95% CI of %
Child characteristics
Sex (F), n(%) 63,065 (48.9%) [48.3, 49.6] 398 (45.6%) [39.3, 52.1]
Age (years), mean ± SD 8.6 ± 0.03 9.2 ± 0.29
Race, n(%)
Hispanic 15,002 (25.1%) [24.4, 25.8] 93 (19.4%) [14.0, 26.2]
White, non-Hispanic 90,845 (50.9%) [50.3,.51.5] 559 (48.8%) [42.5, 55.2]
Black, non-Hispanic 7,978 (13.2%) [12.7, 13.6] 77 (18.2%) [13.6, 24.0]
Multiracial or other, non-Hispanic 16,666 (10.8%) [10.5, 11.1] 106 (13.6%) [9.5, 19.0]
Insurance coverage, n(%)
Currently insured 124,680 (93.4%) [93.0, 93.8] 799 (93.1%) [87.8, 96,2]
Currently uninsured or only insured through Indian Health Service or a religious health share 5,322 (6.3%) [6.0, 6.7] 35 (6.7%) [3.6, 12.1]
Caregiver characteristics
Education status, n(%)
Less than high school 2,988 (9.2%) [8.7, 9.8] 30 (11.0%) [6.8, 17.2]
High school graduate 16,370 (19.3%) [18.8, 19.8] 128 (18.9%) [14.7, 24.1]
More than high school 109,961 (71.5%) [70.8, 72.2] 667 (70.1%) [63.6, 75.9]

Child and caregiver characteristics of 0–17-year-old children with versus without active epilepsy from the 2016–2019 NSCH surveys (n = 131,326). Prevalence figures are weighted to be nationally representative. All p-values for categorical variables reported are Pearson chi-squared values with the Rao-Scott second-order correction to account for weighted survey data; continuous outcomes were compared using the adjusted Wald test. p < 0.05 was considered significant.

Table 2 depicts the odds ratios associated with number of ED visits and percentage of income relative to FPL for those with versus without epilepsy. Ordered logistic regression demonstrated that children who visited the ED more times had incrementally higher odds of having active epilepsy. Children with epilepsy (compared to those without) had 10.2 times the adjusted odds of 2 + ED visits and 2.9 times the adjusted odds of 1 ED visit (compared to 0 ED visits) in the last year. With further calculation, the adjusted odds of 1–2 + ED visits was 5.4 times the odds of 0 ED visits for children with epilepsy compared to those without (not shown in Table 2). Children in lower-income groups also had incrementally higher odds of having active epilepsy. Regression analysis demonstrated that children with epilepsy (compared to those without) had 0.53 times the adjusted odds of an income ≥ 400% FPL, 0.56 times the adjusted odds of an income 200–399% FPL, and 0.65 times the adjusted odds of an income 100–199% FPL compared to 0–99% FPL.

Table 2.

Emergency department visits and average household income among children with versus without active epilepsy.

No active epilepsy
n = 130,491
99.4% [99.3, 99.5]
95% CI of % Active epilepsy
n = 835
0.6% [0.5, 0.7]
95% CI of % OR
[95% CI]
aOR*
[95% CI]
Number of emergency department visits, n(%)
None 107,871 (80.5%) [79.9, 81.0] 449 (48.7%) [42.3, 55.2] ref ref
1 17,566 (15.0%) [14.6, 15.5] 198 (25.2%) [20.2, 31.1] 2.77 [2.03–3.79] 2.91 [2.13–3.98]
2 +  4,535 (4.5%) [4.3, 4.8] 185 (26.1%) [20.7, 32.2] 9.53 [6.87–13.21] 10.17 [7.28–14.20]
Household income, % of federal poverty level, n(%)
0–99% 14,347 (20.2%) [19.6, 20.8] 142 (30.1%) [23.9, 37.2] ref ref
100–199% 20,878 (21.7%) [21.1, 22.2] 171 (20.9%) [16.7, 25.9] 0.65 [0.45–0.94] 0.65 [0.45–0.94]
200–399% 40,357 (27.5%) [27.0, 28.0] 229 (23.5%) [18.5, 29.2] 0.57 [0.39–0.85] 0.56 [0.37–0.83]
 > 400% 54,909 (30.6%) [30.1, 31.1] 293 (25.5%) [20.8, 30.9] 0.56 [0.39–0.80] 0.53 [0.36–0.77]

Univariable logistic regression models detailing the number of emergency department visits and average household income (as % of federal poverty level) among children with versus without active epilepsy from the 2016–19 NSCH (n = 131,326). OR: odds ratio; CI: confidence interval; aOR: adjusted odds ratio.

*aOR adjusted for child age and child race. Results are weighted to be nationally representative. Significance was assessed at the 0.05 level.

Table 3 demonstrates the odds ratios or relative risk ratios for utilization of various medical services/resources between children with and without epilepsy. Overall, compared to their peers, children with epilepsy were more likely to attend preventative medicine visits and less likely to receive needed healthcare. Specifically, 93% of children with epilepsy and 83% of children without epilepsy had seen a healthcare professional for medical care over the last year. Children with epilepsy had 2.7 times the adjusted odds of seeing any healthcare professional for medical care over the last 12 months and 2.3 times the adjusted odds of seeing a healthcare professional for at least one preventative checkup over the last 12 months than their peers. When sick, children with epilepsy had 4.7 times the relative risk of going to a hospital ED (compared to a doctor’s office) and 2.5 times the relative risk of going to a hospital outpatient department (compared to a doctor’s office) than children without epilepsy. Overall, 61% of children with epilepsy received care from a specialist doctor other than a mental health profession compared to only 14% of their peers (aOR: 10.3, CI: 7.7–13.8). Children with epilepsy had 2.6 times the adjusted odds of not receiving needed healthcare than children without (8% versus 3%, respectively). Reasons contributing to why children did not receive needed healthcare services included that the child was not eligible for the needed healthcare services (aOR: 3.2, CI: 1.0[2]-10.2), problems getting an appointment (aOR: 3.9, CI: 2.4–6.4), and transportation issues (aOR: 4.7, CI: 2.0–11.0).

Table 3.

Utilization of medical services among children with versus without active epilepsy.

No active epilepsy
n = 130,491
99.4%
[99.3, 99.5]
95% CI of % Active epilepsy
n = 835
0.6%
[0.5, 0.7]
95% CI of % OR or RRR
(95% CI)
aOR* or aRRR*
(95% CI)
Child saw a healthcare professional for medical care over the last 12 months
No 17,443 (17.0%) [16.5, 17.6] 30 (7.2%) [4.0, 12.8] ref ref
Yes 112,894 (83.0%) [82.5, 83.5] 805 (92.8%) [87.2, 96.0] 2.63 [1.39, 4.97] 2.69 [1.42, 5.10]
Child saw a healthcare professional for at least one preventative checkup over the last 12 months
No 22,111 (20.4%) [19.9, 21.0] 62 (10.1%) [6.4, 15.5] ref ref
Yes 107,504 (79.6%) [79.0, 80.1] 767 (90.0%) [84.5, 93.6] 2.29 [1.40, 3.77] 2.34 [1.43, 3.87]
Place the child usually goes when sick
Doctor’s office 94,422 (75.0%) [74.4, 75.7] 620 (74.4%) [67.2, 80.5] ref ref
Hospital emergency room 799 (1.4%) [1.2, 1.6] 29 (6.8%) [3.9, 11.7] 4.92 [2.67, 9.06] 4.73 [2.44, 9.18]
Hospital outpatient department 549 (0.6%) [0.5, 0.8] 15 (1.7%) [0.7, 3.8] 2.62 [1.09, 6.29] 2.52 [1.04, 6.11]
Clinic/health center 10,109 (8.3%) [7.9, 8.7] 49 (7.0%) [3.4, 14.1] 0.85 [0.39, 1.86] 0.85 [0.40, 1.81]
Minute clinic 950 (0.8%) [0.7, 0.8] 3 (0.5%) [0.1, 1.7] 0.64 [0.18, 2.26] 0.61 [0.17, 2.13]
School 601 (0.4%) [0.3, 0.4] 6 (0.6%) [0.2, 1.9] 1.59 [0.49, 5.22] 1.47 [0.45, 4.79]
Somewhere else 588 (0.5%) [0.4, 0.6] 4 (0.8%) [0.2, 3.5] 1.61 [0.34, 7.67] 1.57 [0.33, 7.44]
Received care from a specialist doctor other than a mental health professional during the past 12 months
No, and he/she needed to 106,109 (84.5%) [84.1, 84.9] 230 (37.3%) [31.1, 43.9] ref ref
No, but he/she needed to 1,869 (1.8%) [1.6, 2.0] 11 (1.8%) [0.9, 3.8] 2.29 [1.04, 5.03] 2.15 [0.98, 4.75]
Yes 21,502 (13.7%) [13.3, 14.1] 586 (60.9%) [54.3, 67.1] 10.05 [7.61, 13.27] 10.32 [7.73, 13.77]
Any times when child needed healthcare but it was not received
Received needed care 126,823 (96.6%) [96.3, 96.9] 775 (92.2%) [87.5, 95.2]
Needed healthcare not received 3,200 (3.0%) [2.8, 3.3] 59 (7.7%) [4.6, 12.4] 2.63 [1.54, 4.52] 2.58 [1.49, 4.46]
Reasons contributing to why child did not receive needed health services:a
Child was not eligible 863 (1.0%) [0.9, 1.1] 16 (3.0%) [1.0, 8.8] 3.25 [1.04, 10.08] 3.22 [1.02, 10.15]
Services were not available in area 743 (0.7%) [0.6, 0.8] 22 (1.2%) [1.0, 3.3] NE NE
Problems getting an appointment 1,213 (1.2%) [1.0, 1.3] 39 (4.5%) [2.9, 7.0] 4.13 [2.54, 6.71] 3.94 [2.41, 6.44]
Transportation issues 359 (0.4%) [0.3, 0.5] 9 (1.9%) [0.8, 4.3] 4.77 [2.02, 11.23] 4.67 [1.99, 10.96]
Clinic/doctor’s office was not open 362 (0.4%) [0.3, 0.5] 8 (1.0%) [0.4, 2.7] 2.80 [1.01, 7.74] 2.72 [0.99, 7.46]
Cost issues 1,956 (1.8%) [1.6, 2.0] 25 (2.3%) [1.3, 4.2] 1.34 [0.72, 2.51] 1.34 [0.72, 2.51]

Utilization of medical services among children with versus without active epilepsy from the 2016–19 NSCH (n = 131,326). OR: odds ratio; RRR: relative risk ratio; CI: confidence interval; aOR: adjusted odds ratio; aRRR: adjusted relative risk ratio; NE: not estimatable. *aOR and aRRR adjusted for child age and child race. Results are weighted to be nationally representative. Significance was assessed for adjusted analyses at the 0.05 level.

aReference: “Did not experience this difficulty in receiving needed medical care”.

Table 4 demonstrates the results of the censored Poisson regression to assess number of ED visits in this sample. The incidence rate of visiting the ED was 2.6 times higher for children with epilepsy than for children without. As children’s income category increased, their adjusted incidence rate of visiting the ED decreased (IRR for 100–199% FPL: 0.73, CI: 0.67–0.80; IRR for 200–399% FPL: 0.55, CI: 0.50–0.60; IRR for ≥ 400% FPL: 0.48, CI: 0.45–0.52). The overall interaction term between epilepsy status and household income category was found to be significant (p = 0.02). Post-hoc analysis of the interaction revealed that the incidence rate ratio associated with epilepsy is 2.04 times higher for children in the 200–399% FPL income category compared to those in the 0–99% FPL income category (IRR 2.04, CI: 1.28–3.24). In other words, the effect of epilepsy on ED visit incidence rate is twice as large for children in the second-to-highest income category compared to those in the lowest income category.

Table 4.

Healthcare utilization among children with versus without active epilepsy.

IRR
[95% CI]
aIRR*
[95% CI]
Active epilepsy 2.52 [1.80–3.52] 2.56 [1.84–3.57]
Household income, % of federal poverty level, n(%)
0–99% Ref Ref
100–199% 0.70 [0.64–0.76] 0.73 [0.67–0.80]
200–399% 0.51 [0.47–0.55] 0.55 [0.50–0.60]
≥ 400% 0.44 [0.40–0.47] 0.48 [0.45–0.52]
Interaction between Household income, % of federal poverty level, n(%) and epilepsy status
0–99% x no epilepsy Ref Ref
100–199% x epilepsy 1.28 [0.79–2.07] 1.34 [0.84–2.16]
200–399% x epilepsy 2.04 [1.28–3.27] 2.04 [1.28–3.24]
≥ 400% x epilepsy 1.30 [0.84–2.03] 1.29 [0.83–2.02]

Censored Poisson regression to assess healthcare utilization (number of emergency room visits over the last 12 months) among children with versus without active epilepsy. Data are from the 2016–19 NSCH (n = 131,326). IRR: incident rate ratio; CI: confidence interval; aIRR: adjusted incident rate ratio.

*aIRR adjusted for child age and child race. Results are weighted to be nationally representative. Significance was assessed for the adjusted analysis at the 0.05 level.

Discussion

We performed a cross-sectional analysis of income and ED utilization among children with versus without epilepsy in the United States, using four years of nationally representative data. In a sample of 131,326 children, our results demonstrate that children with epilepsy had significantly higher odds of: having lower household income, visiting the ED more frequently, and not receiving needed healthcare. We also found that income did not incrementally moderate the effect of epilepsy status on number of ED visits.

From this weighted sample, we estimated the national prevalence of epilepsy to be 0.59%. Scaled to the US population (estimated size: 73,084,673), this represents approximately 431,200 children, which is slightly lower than the current estimate of 470,0002. We expect that some children in the sample, especially those who “were ever told they had epilepsy or seizure disorder”, may actually have had epilepsy, leading to potential underrepresentation of the true population of US children with epilepsy.

The first objective of this analysis was to assess whether US children with epilepsy had lower income than those without. Such a relationship has been well-evidenced in US adult and non-US populations. A recent meta-analysis by Fiest et al. demonstrated that the active annual period prevalence of epilepsy was higher in low-to-middle income countries than high-income countries13. Regarding differences in SES among patients within individual countries, Noronha et al. demonstrated in a Brazilian population that (even after adjusting for differences in treatment) there was a higher prevalence of epilepsy among lower-income patients14. In Sweden, Li et al. revealed that lower education status and lower income were both associated with increased risk of hospitalization for epilepsy15. Evidence from a national study in Iceland suggests that the risk of epilepsy is higher in adults with low socioeconomic status, but that the same relationship does not exist for children5. Moreover, in Zambia, Birbeck et al. found that people with epilepsy not only had lower education status, but also poorer living conditions than those without epilepsy16. SES and/or income have been evidenced to profoundly influence treatment adherence, morbidity, and mortality among epilepsy patients5,6,8,9.

The above-mentioned findings reflect non-US or primarily adult populations. Evidence for an association between epilepsy and income/SES in children is mixed17, yet lower SES in epilepsy has been associated with delayed care and potentially worse outcomes in children with epilepsy from other developed countries18,19. Our results in an exclusively US pediatric sample demonstrated that even after adjusting for age and race, children with epilepsy had 1.47 times the odds (the reciprocal of OR = 0.68, as presented) of having lower income than their peers. The socioeconomic status of children in this analysis is a reflection of the socioeconomic status of their caregivers. Given that a large proportion of epilepsy etiologies are associated with genetic alterations20,21, it is possible that some children in this analysis with epilepsy have a caregiver with epilepsy. The average total annual direct healthcare cost of epilepsy per person in the United States is estimated to range from $10,000-$48,00022. Coupled with evidence that adults with epilepsy are more likely to be unemployed or unable to work and have comorbid health conditions23 which may pose additional barriers in accessing necessary treatment for their children, a “downward socioeconomic spiral” may exist. Thus, it is possible that children with epilepsy in our study may have had lower income their caregivers also had epilepsy themselves. An additional theory is that perhaps caregivers of patients with epilepsy are unable to dedicate time to earning income because they must care for their child. In short, it is unclear the directionality of the relationship between epilepsy in children and their household income.

Our second objective was to assess whether children with epilepsy utilized medical resources more than those without epilepsy. Existing literature suggests that adults living with epilepsy and lower income have higher healthcare utilization and concomitantly worse epilepsy outcomes24. Children with epilepsy had 10 times the incidence rate of 2 + ED visits than 0 visits than children without epilepsy. The NSCH data does not offer information on the reason for these increased ED visits. However, we speculate a few reasons for this finding. However, it is likely that many of these additional ED visits were related to epilepsy: increased seizure activity, injuries related to seizure activity, or for emergency antiseizure medication-related adverse events. Seizures and epilepsy care are the most common neurological reason for presentation to an ED25. Visiting the ED is economically- and psychologically-taxing for patients and caregivers. It has further been argued that many ED visits for epilepsy could be avoided26. Ryan et al. found that the financial cost associated with pediatric epilepsy is highest (around $20,000) the first year after diagnosis, and that ED visits comprise the third-highest cost (second only to hospital admissions and diagnostic procedures) while only accounting for 1% of total visits26. Patel et al. demonstrated that a targeted intervention (focused on five key interventions: establishing an urgent epilepsy clinic, improving at-home seizure management plans, making information on proper abortive seizure medication dosing more accessible, reminder magnets with information on abortive seizure medications, and targeting unique issues for patients who tended to use the ED frequently) reduced ED visits by 28% over 19 months27.

Crucially, our analysis suggests that children with epilepsy are 2.6 more likely to not receive needed healthcare. The primary reasons cited for lack of needed care were: the child was not eligible for needed healthcare services, caregivers had difficulty getting an appointment, and transportation was a prohibitive factor. Lack of adequate treatment for epilepsy has been associated with worse epilepsy outcomes including higher mortality rates in those with untreated epilepsy28. These factors are similar to those targeted by Patel et al. in their single-center project. The results of analysis provide meaningful potential targets health policy targets to improve access to epilepsy care for US children. Our study demonstrated that transportation barriers are the most burdensome for caregivers. That said, the results of this analysis are reflective of the statistically weighted national population (with the limitation that the raw data derives from caregivers who responded to the telephone survey). Each community is unique in its barriers to healthcare. Solomon et al. in a recent systematic review, suggest that making transportation more affordable or easy-to-access, while important, may not be sufficient by itself to improve access to needed healthcare resources29. Thus, community-based, institutional- or state-level targeted interventions, like that performed by Patel et al., may be the most effective way to identify and target the unique factors contributing to lack of access to needed healthcare.

The final objective of this analysis was to determine whether the association of epilepsy with ED utilization was moderated by income. Unlike some other developed countries19, the US lacks universal healthcare or centralized epilepsy care delivery mechanisms. Our results revealed evidence that the effect of having active epilepsy on ED usage may differ by income category. Evidence in adults samples indicates that some of the primary drivers of the moderation effect of income on healthcare resource utilization are differences in health at baseliney3033. Our analysis focused on children, who likely have similar baseline health status to each other compared with adults. Perhaps children with epilepsy in higher income groups have fewer limitations in access to EDs than children at or below FLP. In conjunction, they may have more events inciting EDs visits than children without epilepsy. Still, the interaction between income category and epilepsy status was not incremental, as expected. Thus, the results of this moderation analysis provide evidence of a potential interaction between epilepsy status and income on ED utilization, but the true nature and underlying reasons for this effect require further investigation.

Limitations and future work

This study has several limitations. First, it is cross-sectional in nature, and is limited by biases which limit all cross-sectional studies. No inferences about causation, only correlations and associations, can be drawn from our results. That said, the data used for this analysis reflected over 131,000 children in the US and were weighted to reflect the US population. This analysis also extended only to 2019 due to availability of data. Considering the significant socioeconomic changes brought forth by the global pandemic, it will become critical to re-characterize the state of income and healthcare utilization among children with epilepsy in the post-pandemic era so that specific local-, state-, and federal-level interventions can be designed to improve access to epilepsy care. Importantly, we included children whose caregivers were unsure of their epilepsy status into the group of children without active epilepsy rather than excluding them entirely. This was done for two reasons: (1) to optimize our study’s generalizability, and (2) we felt if we had excluded these patients, it may have introduced a selection bias against patients with less social, financial, or healthcare resources to bring a one-time seizure or follow up on a questioned diagnosis of epilepsy to medical attention. This, however, is a limitation of our study’s internal validity. Finally, this analysis used simple proxies for complex socioeconomic concepts. Income was used as a rough gauge of SES and ED visits were used as a rough gauge of healthcare utilization. These was chosen based on precedents set in prior literature, based on data availability, and due to lack of standardized and validated methodology for utilizing base survey data to derive complex composite variables like SES or healthcare resource utilization. If future studies were able to validate such derivation methods for use in large-scale dataset analysis, researchers would be able to make even better use of the rich data available from well-performed cross-sectional studies like the NSCH, and more comprehensive, nuanced characterizations of complex socioeconomic constructs would be possible.

Conclusions

Children with epilepsy are more likely than their peers to live in lower income households, visit an ED, and see healthcare professionals. Income category does not incrementally moderate the relationship between epilepsy status and ED utilization. Children with active epilepsy had 2.6 times the odds of not receiving necessary healthcare, with the most common barriers being: service eligibility, appointment scheduling, and transport. Health policy interventions to alleviate these barriers will improve access to needed medical care for children with epilepsy specifically, and for those with other chronic medical conditions broadly.

Author contributions

The authors confirm contribution to the paper as follows: study conception and design: T.J.A., N.M.; data collection: N.M., S.R.; analysis and interpretation of results: N.M., S.R.; draft manuscript preparation: N.M., T.J.A. All authors reviewed the results and approved the final version of the manuscript.

Data availability

All data and supporting documentation are publicly available from the Health Resources and Services Administration’s Maternal and Child Health Bureau (https://mchb.hrsa.gov/data/national-surveys). Data access: Authors NM and SR had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Data sharing statement: Data are publicly available for download from the National Survey of Children’s Health website (https://www.childhealthdata.org/learn-about-the-nsch/nsch-codebooks).

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–482. doi: 10.1111/epi.12550. [DOI] [PubMed] [Google Scholar]
  • 2.Zack MM, Kobau R. National and state estimates of the numbers of adults and children with active epilepsy—United States, 2015. MMWR Morb. Mortal Wkly Rep. 2017;66(31):821–825. doi: 10.15585/mmwr.mm6631a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia. 2018;59(12):2179–2193. doi: 10.1111/epi.14596. [DOI] [PubMed] [Google Scholar]
  • 4.Szaflarski M. Social determinants of health in epilepsy. Epilepsy Behav. 2014;41:283–289. doi: 10.1016/j.yebeh.2014.06.013. [DOI] [PubMed] [Google Scholar]
  • 5.Hesdorffer DC, Tian H, Anand K, et al. Socioeconomic status is a risk factor for epilepsy in Icelandic adults but not in children. Epilepsia. 2005;46(8):1297–1303. doi: 10.1111/j.1528-1167.2005.10705.x. [DOI] [PubMed] [Google Scholar]
  • 6.Burneo JG, Jette N, Theodore W, et al. Disparities in epilepsy: report of a systematic review by the North American Commission of the International League Against Epilepsy. Epilepsia. 2009;50(10):2285–2295. doi: 10.1111/j.1528-1167.2009.02282.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Saadi A, Himmelstein DU, Woolhandler S, Mejia NI. Racial disparities in neurologic health care access and utilization in the United States. Neurology. 2017;88(24):2268–2275. doi: 10.1212/WNL.0000000000004025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ficker DM. Sudden unexplained death and injury in epilepsy. Epilepsia. 2000;41(Suppl 2):S7–12. doi: 10.1111/j.1528-1157.2000.tb01519.x. [DOI] [PubMed] [Google Scholar]
  • 9.Nilsson L, Farahmand BY, Persson PG, Thiblin I, Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet. 1999;353(9156):888–893. doi: 10.1016/s0140-6736(98)05114-9. [DOI] [PubMed] [Google Scholar]
  • 10.Huber R, Weber P. Is there a relationship between socioeconomic factors and prevalence, adherence and outcome in childhood epilepsy? A systematic scoping review. Eur. J. Paediatr. Neurol. 2022;38:1–6. doi: 10.1016/j.ejpn.2022.01.021. [DOI] [PubMed] [Google Scholar]
  • 11.Bureau, U.C. Guide to Multi-Year Analysis. Commerce UDo; 2021. https://www2.census.gov/programs-surveys/nsch/technical-documentation/methodology/NSCH-Guide-to-Multi-Year-Estimates.pdf
  • 12.Miller R, Tumin D, Hayes D, Jr, Uffman JC, Raman VT, Tobias JD. Unmet need for care coordination among children with special health care needs. Popul. Health Manag. 2019;22(3):255–261. doi: 10.1089/pop.2018.0094. [DOI] [PubMed] [Google Scholar]
  • 13.Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296–303. doi: 10.1212/WNL.0000000000003509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Noronha AL, Borges MA, Marques LH, et al. Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia. 2007;48(5):880–885. doi: 10.1111/j.1528-1167.2006.00974.x. [DOI] [PubMed] [Google Scholar]
  • 15.Li X, Sundquist J, Sundquist K. Socioeconomic and occupational risk factors for epilepsy: a nationwide epidemiological study in Sweden. Seizure. 2008;17(3):254–260. doi: 10.1016/j.seizure.2007.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Birbeck G, Chomba E, Atadzhanov M, Mbewe E, Haworth A. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol. 2007;6(1):39–44. doi: 10.1016/S1474-4422(06)70629-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Durkin MS, Yeargin-Allsopp M. Socioeconomic status and pediatric neurologic disorders: current evidence. Semin. Pediatr. Neurol. 2018;27:16–25. doi: 10.1016/j.spen.2018.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Geerts A, Brouwer O, van Donselaar C, et al. Health perception and socioeconomic status following childhood-onset epilepsy: the Dutch study of epilepsy in childhood. Epilepsia. 2011;52(12):2192–2202. doi: 10.1111/j.1528-1167.2011.03294.x. [DOI] [PubMed] [Google Scholar]
  • 19.Puka K, Smith ML, Moineddin R, Snead OC, Widjaja E. The influence of socioeconomic status on health resource utilization in pediatric epilepsy in a universal health insurance system. Epilepsia. 2016;57(3):455–463. doi: 10.1111/epi.13290. [DOI] [PubMed] [Google Scholar]
  • 20.Kjeldsen MJ, Corey LA, Christensen K, Friis ML. Epileptic seizures and syndromes in twins: the importance of genetic factors. Epilepsy Res. Jun-Jul. 2003;55(1–2):137–146. doi: 10.1016/s0920-1211(03)00117-7. [DOI] [PubMed] [Google Scholar]
  • 21.Myers CT, Mefford HC. Advancing epilepsy genetics in the genomic era. Genome Med. 2015 doi: 10.1186/s13073-015-0214-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Begley CE, Durgin TL. The direct cost of epilepsy in the United States: A systematic review of estimates. Epilepsia. 2015;56(9):1376–1387. doi: 10.1111/epi.13084. [DOI] [PubMed] [Google Scholar]
  • 23.Kobau R, Zahran H, Thurman DJ, et al. Epilepsy surveillance among adults–19 States, Behavioral Risk Factor Surveillance System, 2005. MMWR Surveill. Summ. 2008;57(6):1–20. [PubMed] [Google Scholar]
  • 24.Groover O, Morton ML, Janocko NJ, et al. Mind the gap: health disparities in families living with epilepsy are significant and linked to socioeconomic status. Epileptic Disord. 2020;22(6):782–789. doi: 10.1684/epd.2020.1229. [DOI] [PubMed] [Google Scholar]
  • 25.Pallin DJ, Goldstein JN, Moussally JS, Pelletier AJ, Green AR, Camargo CA., Jr Seizure visits in US emergency departments: epidemiology and potential disparities in care. Int. J. Emerg. Med. 2008;1(2):97–105. doi: 10.1007/s12245-008-0024-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ryan JL, McGrady ME, Guilfoyle SM, Junger K, Arnett AD, Modi AC. Health care charges for youth with newly diagnosed epilepsy. Neurology. 2015;85(6):490–497. doi: 10.1212/WNL.0000000000001746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Patel AD, Wood EG, Cohen DM. Reduced emergency department utilization by patients with epilepsy using QI methodology. Pediatrics. 2017 doi: 10.1542/peds.2015-2358. [DOI] [PubMed] [Google Scholar]
  • 28.Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185–191. doi: 10.1159/000503831. [DOI] [PubMed] [Google Scholar]
  • 29.Solomon EM, Wing H, Steiner JF, Gottlieb LM. Impact of Transportation Interventions on Health Care Outcomes: A Systematic Review. Med Care. 2020;58(4):384–391. doi: 10.1097/MLR.0000000000001292. [DOI] [PubMed] [Google Scholar]
  • 30.Droomers M, Westert GP. Do lower socioeconomic groups use more health services, because they suffer from more illnesses? Eur J Public Health. 2004;14(3):311–313. doi: 10.1093/eurpub/14.3.311. [DOI] [PubMed] [Google Scholar]
  • 31.Loef B, Meulman I, Herber GM, et al. Socioeconomic differences in healthcare expenditure and utilization in The Netherlands. BMC Health Serv. Res. 2021 doi: 10.1186/s12913-021-06694-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Meulman I, Uiters E, Polder J, Stadhouders N. Why does healthcare utilisation differ between socioeconomic groups in OECD countries with universal healthcare coverage? A protocol for a systematic review. BMJ Open. 2021 doi: 10.1136/bmjopen-2021-054806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.van Doorslaer E, Wagstaff A, van der Burg H, et al. Equity in the delivery of health care in Europe and the US. J Health Econ. 2000;19(5):553–583. doi: 10.1016/s0167-6296(00)00050-3. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data and supporting documentation are publicly available from the Health Resources and Services Administration’s Maternal and Child Health Bureau (https://mchb.hrsa.gov/data/national-surveys). Data access: Authors NM and SR had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Data sharing statement: Data are publicly available for download from the National Survey of Children’s Health website (https://www.childhealthdata.org/learn-about-the-nsch/nsch-codebooks).


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES